Zobrazeno 1 - 10
of 721
pro vyhledávání: '"Elston Lafata J"'
Autor:
Fridman I; University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, 450 West Dr, Chapel Hill, NC 27599. Email: Ilona_fridman@med.unc.edu., Carter-Bawa L, Neslund-Dudas CM, Elston Lafata J
Publikováno v:
The American journal of managed care [Am J Manag Care] 2024 Sep; Vol. 30 (9), pp. 440-444.
Autor:
Fridman I; Lineberger Cancer Center, University of North Carolina, USA., Bylund CL; The University of Florida, College of Medicine, USA., Elston Lafata J; Lineberger Cancer Center, University of North Carolina, USA.
Publikováno v:
PEC innovation [PEC Innov] 2024 Aug 17; Vol. 5, pp. 100332. Date of Electronic Publication: 2024 Aug 17 (Print Publication: 2024).
Autor:
Alishahi Tabriz A; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL.; Department of Oncological Sciences, University of South Florida Morsani College of Medicine, Tampa, FL., Turner K; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL.; Department of Oncological Sciences, University of South Florida Morsani College of Medicine, Tampa, FL., Hemati H; Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC., Baugh C; Department of Emergency Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA., Elston Lafata J; Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jul 22, pp. OP2400160. Date of Electronic Publication: 2024 Jul 22.
Autor:
Ray EM; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; University of North Carolina at Chapel Hill School of Medicine, Division of Oncology, Chapel Hill, NC., Elston Lafata J; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, Chapel Hill, NC., Reeder-Hayes KE; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; University of North Carolina at Chapel Hill School of Medicine, Division of Oncology, Chapel Hill, NC., Thompson CA; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; University of North Carolina at Chapel Hill Gillings School of Global Public Health, Department of Epidemiology, Chapel Hill, NC.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 20; Vol. 42 (21), pp. 2491-2494. Date of Electronic Publication: 2024 May 15.
Autor:
Muluneh B; 1UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.; 2UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Collins JB; 1UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.; 3GSK, Durham, NC., Lam B; 1UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Mackler E; 4Michigan Medicine, Ann Arbor, MI., Elston Lafata J; 1UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.; 2UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Mar 19; Vol. 22 (3), pp. 167-174. Date of Electronic Publication: 2024 Mar 19.
Autor:
Tam S; Department of Public Health Sciences, Henry Ford Health, Detroit, MI, USA.; Department of Otolaryngology, Henry Ford Health, Detroit, MI, USA.; Department of Surgery, College of Human Medicine, Michigan State University, East Lansing, MI, USA., Neslund-Dudas C; Department of Public Health Sciences, Henry Ford Health, Detroit, MI, USA.; Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, MI, USA., Barrett AM; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA., Barrow LCJ; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Fridman I; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Kinlaw AC; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Puviindran P; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA., Royce TJ; Department of Radiation, Wake Forest School of Medicine, Winston-Salem, NC, USA., Smith AB; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Stein JN; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Wood WA; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Elston Lafata J; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Publikováno v:
The oncologist [Oncologist] 2024 Feb 02; Vol. 29 (2), pp. e237-e247.
Autor:
Rendle KA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (K.A.R., C.A.S., A.V., S.B., R.Y.K., J.V.W., N.M.)., Saia CA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (K.A.R., C.A.S., A.V., S.B., R.Y.K., J.V.W., N.M.)., Vachani A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (K.A.R., C.A.S., A.V., S.B., R.Y.K., J.V.W., N.M.)., Burnett-Hartman AN; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado (A.N.B., D.R.)., Doria-Rose VP; Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (V.P.D.)., Beucker S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (K.A.R., C.A.S., A.V., S.B., R.Y.K., J.V.W., N.M.)., Neslund-Dudas C; Henry Ford Health and Henry Ford Cancer Institute, Detroit, Michigan (C.N.)., Oshiro C; Center for Integrated Healthcare Research, Kaiser Permanente Hawaii, Honolulu, Hawaii (C.O.)., Kim RY; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (K.A.R., C.A.S., A.V., S.B., R.Y.K., J.V.W., N.M.)., Elston-Lafata J; Henry Ford Health and Henry Ford Cancer Institute, Detroit, Michigan, and Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (J.E.)., Honda SA; Center for Integrated Health Care Research, Kaiser Permanente Hawaii, and Hawaii Permanente Medical Group, Honolulu, Hawaii (S.A.H.)., Ritzwoller D; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado (A.N.B., D.R.)., Wainwright JV; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (K.A.R., C.A.S., A.V., S.B., R.Y.K., J.V.W., N.M.)., Mitra N; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (K.A.R., C.A.S., A.V., S.B., R.Y.K., J.V.W., N.M.)., Greenlee RT; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin (R.T.G.).
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2024 Jan; Vol. 177 (1), pp. 18-28. Date of Electronic Publication: 2024 Jan 02.
Autor:
Stein JN; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC., Dunham L; North Carolina Cancer Hospital, Chapel Hill, NC., Wood WA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Division of Hematology, Department of Medicine, University of North Carolina, Chapel Hill, NC., Ray E; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC., Sanoff H; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC.; North Carolina Cancer Hospital, Chapel Hill, NC., Elston-Lafata J; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Divison of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2023 Aug; Vol. 19 (8), pp. 577-585. Date of Electronic Publication: 2023 May 22.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Muluneh B; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Muir MA; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Collins JB; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Proco D; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Mackler E; Michigan Oncology Quality Consortium, Ann Arbor, MI, United States of America., Leak Bryant A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Wood WA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Tilkens M; Department of Pharmacy, University of North Carolina Medical Centerat Chapel Hill, Chapel Hill, North Carolina, United States of America., Reichard JS; Department of Pharmacy, University of North Carolina Medical Centerat Chapel Hill, Chapel Hill, North Carolina, United States of America., Foster M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Gatwood J; College of Pharmacy, University of Tennessee Health Science Center at Memphis, Memphis, Tennessee, United States of America., Wheeler SB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Zullig LL; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, NC, United States of America., Elston Lafata J; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Publikováno v:
PloS one [PLoS One] 2023 Jul 21; Vol. 18 (7), pp. e0286630. Date of Electronic Publication: 2023 Jul 21 (Print Publication: 2023).